Prevalence of tuberculin skin test positivity in clinical population in New York city

Journal of Immigrant and Minority Health

Volumn 12, Issue 6, 2010, Pages 816-822

  Li, Jiehui ^a   Munsiff, Sonal S ^a,b   Agerton, Tracy B ^a,b  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Immigrants; Prevalence; Tuberculin skin test

Indexed keywords

TUBERCULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; ETHNOLOGY; FACTUAL DATABASE; FEMALE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MIGRATION; OUTPATIENT DEPARTMENT; PRESCHOOL CHILD; PREVALENCE; SKIN; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE FACILITIES; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; EMIGRANTS AND IMMIGRANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW YORK CITY; PREVALENCE; SKIN; TUBERCULIN; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 78649629243     PISSN: 15571912     EISSN: 15571920     Source Type: Journal    
DOI: 10.1007/s10903-008-9204-9     Document Type: Article

References (22)

1. Centers for Disease Control and Prevention (CDC) 2000 Targeted tuberculin testing and treatment of latent tuberculosis infection Morb Mortal Wkly Rep 49 RR-6 1 51
2. Institute of Medicine (US). Committee on the Elimination of Tuberculosis in the United States. In: Geiter L, editor. Ending neglect: the elimination of tuberculosis in the United States. Washington, DC: National Academy Press; 2000.
3. Centers for Disease Control, Prevention (CDC). Reported Tuberculosis in the United States, 2006. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2007.
4. New York City Department of Health and Mental Hygiene: Tuberculosis in New York City, 2005: Annual Summary. New York City Department of Health and Mental Hygiene; 2006.
5. DE Bennett JM Courval I Onorato T Agerton J Daugherty Gibson L Lambert G McQuillan B Lewis TR Navin KG Castro 2007 Prevalence of tuberculosis infection in the U.S. population Am J Respir Crit Care Med 177 3 348 55 10.1164/rccm.200701-057OC 17989346
6. TJ Joos WC Miller DM Murdoch 2006 Tuberculin reactivity in bacilli Calmette-Guerin vaccinated populations: a compilation of international data Int J Tuberc Lung Dis 10 8 883 91 1:STN:280:DC%2BD28vnsVOhuw%3D%3D 16898373
7. New York City Department of City Planning. 2000 census profiles. Available at: http://www.nyc.gov/html/dcp/pdf/census.shtml.
8. US Census Bureau. United States Census 2000: demographic profiles in the Unites States. Available at: http://censtats.census.gov/data/US/01000.pdf.
9. Fujiwara PI, Munsiff SS, Shapiro D. Testing and treatment for latent tuberculosis infection. City Health Information. New York: New York City Department of Health. 2000 Oct; 19(3). Available at: http://home2.nyc.gov/html/ doh/downloads/pdf/chi/chi19-3.pdf.
10. World Health Organization (WHO). Global tuberculosis control: surveillance, planning, financing. WHO Report 2005. Geneva, Switzerland, WHO/HTM/TB/2005.349.
11. World Health Organization. WHO vaccine-preventable diseases: monitoring system: 2005 global summary. Geneva, Switzerland: WHO; 2005. WHO/IVB/2005. Available at www.who.int/vaccines-documents/.
12. S Greenland 2004 Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies Am J Epidemiol 160 301 5 10.1093/aje/kwh221 15286014 (Pubitemid 39045260)
13. D Spiegelman E Hertzmark 2005 Easy SAS calculations for risk or prevalence ratios and differences Am J Epidemiol 162 199 205 10.1093/aje/kwi188 15987728 (Pubitemid 41373523)
14. N Pearce 2004 Effect measures in prevalence studies Environ Health Perspect 112 1047 50 10.1289/ehp.6927 15238274
15. M Pai LW Riley JM Colford Jr 2004 Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review Lancet Infect Dis 4 761 76 1:CAS:528:DC%2BD2MXisV2lug%3D%3D 10.1016/S1473-3099(04)01206-X 15567126 (Pubitemid 39574348)
16. GH Mazurek J Jereb P LoBue MF Iademarco B Metchock A Vernon Division of Tuberculosis Elimination STD Centers for Disease Control and Prevention (CDC) 2005 Guidelines for using the QuantFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States MMWR Recomm Rep 54 RR-15 49 55 16357824
17. M Pai K Dheda J Cunningham F Scano R O'Brien 2007 T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward Lancet Infect Dis 7 6 428 38 10.1016/S1473-3099(07)70086-5 17521596 (Pubitemid 46779096)
18. CM Nolan SV Goldberg SE Buskin 1999 Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic JAMA 281 1014 18 1:STN:280:DyaK1M7osVansg%3D%3D 10.1001/jama.281.11.1014 10086436 (Pubitemid 29143893)
19. SR Salpeter GD Sanders EE Salpeter DK Owens 1997 Monitored isoniazid prophylaxis for low-risk tubercullin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis Ann Intern Med 127 1051 61 1:CAS:528:DyaK1cXhtF2ksg%3D%3D 9412307
20. NW Schluger R Huberman N Wolinsky R Dooley WN Rom RS Holzman 1997 Tuberculosis infection and disease among persons seeking social services in New York City Int J Tuberc Lung Dis 1 31 7 1:STN:280:DyaK1c%2FlvFCntQ%3D%3D 9441056
21. J Hudson S Van Zetta B Brissette CR Driver M Macaraig A Winters S Poonja SS Munsiff M Beatty, et al. 2005 Tuberculosis transmission in a homeless shelter population-New York, 2000-2003 MMWR 54 149 52
22. M Farhat C Greenaway M Pai D Menzies 2006 False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 10 11 1192 204 1:STN:280:DC%2BD28npsVWksw%3D%3D 17131776